Article
Assessing CSF ctDNA to Improve Diagnostic Accuracy and Therapeutic Monitoring in Breast Cancer Leptomeningeal Metastasis.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Mar 2022
Fitzpatrick Amanda, Iravani Marjan, Mills Adam, Childs Lucy, Alaguthurai Thanussuyah, Clifford Angela, Garcia-Murillas Isaac, Van Laere Steven, Dirix Luc, Harries Mark, Okines Alicia, Turner Nicholas C, Haider Syed, Tutt Andrew N J, Isacke Clare M
Abstract excerpt
PURPOSE: Cerebrospinal fluid (CSF) cytology is the gold standard diagnostic test for breast cancer leptomeningeal metastasis (BCLM), but has impaired sensitivity, often necessitating repeated lumbar puncture to confirm or refute diagnosis. Further, there is no quantitative response tool to assess response or progression during BCLM treatment. EXPERIMENTAL DESIGN: Facing the challenge of working with small-volume...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
